Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neuroleptic”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT02462473
What this trial is testing

Assess the Clinical Utility of Antipsychotic Medication Levels in Plasma as Determined by Liquid Chromatography-Tandem Mass Spectrometry

Who this might be right for
SchizophreniaSchizoaffective Disorder
Janssen Research & Development, LLC 9
Not applicableStudy completedNCT02366897
What this trial is testing

Extrapyramidal Side-Effects in Antipsychotic Drug Therapeutics

Who this might be right for
Drug-induced Extrapyramidal Side Effects
University of Edinburgh 21
Testing effectiveness (Phase 2)Study completedNCT00097942
What this trial is testing

Evaluation of the Safety and Efficacy of Memantine as Adjunctive Treatment in Schizophrenia Patients

Who this might be right for
Schizophrenia
Forest Laboratories 138
Post-approval studies (Phase 4)Study completedNCT00417482
What this trial is testing

Antipsychotic Discontinuation in Alzheimer's Disease

Who this might be right for
Alzheimer DiseasePsychotic DisordersAgitation+1 more
New York State Psychiatric Institute 180
Large-scale testing (Phase 3)Looking for participantsNCT07565428
What this trial is testing

Study to Evaluate Efficacy and Safety of Roluperidone in Adult Subjects With Negative Symptoms and Stable Positive Symptoms of Schizophrenia and to Evaluate the Relapse Rate of Roluperidone and Antipsychotic Medications

Who this might be right for
Negative Symptoms of Schizophrenia
Minerva Neurosciences 380
Early research (Phase 1)Study completedNCT01607762
What this trial is testing

Compare Capillary and Venous Whole Blood and Plasma Concentrations of Five Antipsychotics

Who this might be right for
Healthy
Janssen Research & Development, LLC 31
Not applicableStudy completedNCT00065286
What this trial is testing

Akathisia (Restless Legs Syndrome) in People With Schizophrenia and Mental Retardation

Who this might be right for
Akathisia
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Post-approval studies (Phase 4)UnknownNCT00837707
What this trial is testing

Aripiprazole for Neuroleptic-Induced Tardive Dyskinesia

Who this might be right for
Dyskinesia, Drug-Induced
Taoyuan Psychiatric Center, Ministry of Health and Welfare, Executive Yuan, R.O.C. Taiwan 25
Large-scale testing (Phase 3)Study completedNCT02013622
What this trial is testing

Monotherapy Brexpiprazole (OPC-34712) Trial in the Treatment of Adults With Early-Episode Schizophrenia

Who this might be right for
Schizophrenia
Otsuka Pharmaceutical Development & Commercialization, Inc. 49
Post-approval studies (Phase 4)Study completedNCT00373672
What this trial is testing

Effects of Armodafinil on Cognition for Patients With Schizophrenia or Schizoaffective Disorder

Who this might be right for
SchizophreniaSchizoaffective Disorder
Northwestern University 58
Large-scale testing (Phase 3)Looking for participantsNCT07363577
What this trial is testing

Study to Evaluate LB-102 for the Treatment of Adult Patients With Acute Schizophrenia

Who this might be right for
Schizophrenia
LB Pharmaceuticals Inc. 456
Early research (Phase 1)Study completedNCT05712265
What this trial is testing

Study to Evaluate the Effects of a Cytochrome P450 2C19 Inhibitor on the Pharmacokinetics of Miricorilant

Who this might be right for
Antipsychotic Induced Weight GainNon-alcoholic Steatohepatitis (NASH)
Corcept Therapeutics 26
Not applicableStudy completedNCT00174200
What this trial is testing

Study To Assess Differential Sensitivity Of 2 Spatial Working Memory Tests In Schizophrenics Treated With Risperidone

Who this might be right for
SchizophreniaPsychotic Disorders
Pfizer 20
Testing effectiveness (Phase 2)Study completedNCT01636037
What this trial is testing

Antipsychotic Augmentation With L-Dopa

Who this might be right for
Schizophrenia
Centre for Addiction and Mental Health 13
Not applicableStudy completedNCT00448630
What this trial is testing

An Observational Study On Metabolic Syndrome Parameters In Schizophrenia Patients Treated With Atypical Antipsychotics

Who this might be right for
SchizophreniaMetabolic Syndrome X
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 328
Not applicableStudy completedNCT02281162
What this trial is testing

The Influence of Vitamin D on Atypical Antipsychotic-induced Weight Gain

Who this might be right for
SchizophreniaMetabolic SyndromeVitamin D Deficiency
Creighton University 20
Post-approval studies (Phase 4)Study completedNCT02526030
What this trial is testing

Comparative Study of Aripiprazole, Quetiapine and Ziprasidone in Treatment of First Episode Psychosis: 3-year Follow-up

Who this might be right for
SchizophreniaPsychotic Disorders
Fundación Marques de Valdecilla 203
Testing effectiveness (Phase 2)Study completedNCT01875822
What this trial is testing

Open-label Study of Curcumin C-3 Complex in Schizophrenia

Who this might be right for
SchizophreniaSchizoaffective DisorderDepression
Woodbury, Michel, M.D. 17
Not applicableStudy completedNCT01245348
What this trial is testing

Relative Effectiveness of Schizophrenia Therapy Study

Who this might be right for
SchizophreniaBipolar Disorder
Medco Health Solutions, Inc. 1,110
Not applicableUnknownNCT03155685
What this trial is testing

Use of Antipsychotics in Palliative Care (NEUROPAL)

Who this might be right for
Antipsychotics in Palliative Care
University Hospital, Caen 100
Next Page